Hence, here, we suggested a novel strategy for AKI management using STAT3 inhibitors as the inhibition of STAT3 signaling alleviated the progression of acute kidney injury to chronic kidney disease through anti-apoptosis. This evidence concerns the gene STAT3 and chronic kidney disease.